Voya Investment Management LLC Global Blood Therapeutics, Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $1.84 Million - $3.88 Million	-56,913 Reduced 69.71%	24,727 $1.68 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $1.28 Million - $2.14 Million	57,245 Added 234.66%	81,640 $2.61 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $24,036 - $33,312	936 Added 3.99%	24,395 $845,000
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $622 - $1,006	25 Added 0.11%	23,459 $687,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $121,075 - $161,956	3,730 Added 18.93%	23,434 $821,000
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $47,584 - $62,138	-1,222 Reduced 5.84%	19,704 $803,000
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $29,555 - $50,059	-785 Reduced 3.62%	20,926 $906,000
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $6.3 Million - $8.9 Million	-119,485 Reduced 84.62%	21,711 $1.2 Million
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $4.44 Million - $7.45 Million	-91,057 Reduced 39.21%	141,196 $8.91 Million
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $663,431 - $1.39 Million	15,902 Added 7.35%	232,253 $11.9 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $710,680 - $1.27 Million	15,551 Added 7.74%	216,351 $17.2 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $1.46 Million - $1.87 Million	-32,274 Reduced 13.85%	200,800 $9.74 Million
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $2.06 Million - $2.48 Million	-39,163 Reduced 14.39%	233,074 $12.3 Million
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $3.33 Million - $4.46 Million	-83,381 Reduced 23.45%	272,237 $14.4 Million
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $3.62 Million - $5.36 Million	-114,831 Reduced 24.41%	355,618 $14.6 Million
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $17.1 Million - $23 Million	450,823 Added 2297.07%	470,449 $17.9 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $114,126 - $147,892	2,949 Added 17.68%	19,626 $887,000
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $594 - $988	-15 Reduced 0.09%	16,677 $805,000
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $11,583 - $17,823	-390 Reduced 2.28%	16,692 $657,000
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $428,758 - $530,396	17,082	17,082 $530,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account